Skin Cancer and Melanoma Clinical Program Archives - Page 2 of 4

UNC Lineberger's Carrie Lee, MD, spoke at the “Understanding Melanoma: From Prevention to Treatment" seminar on May 14.

UNC Lineberger and the Melanoma Research Foundation hosted “Understanding Melanoma: From Prevention to Treatment," a seminar for patients and caregivers at the William and Ida Friday Center for Continuing Education in Chapel Hill. Physicians, researchers, patients and staff spoke about advances in treatment and care for melanoma, research and prevention, as well as best practices to address the psychosocial aspects of care.

Three of 15 patients with BRAF-mutant melanoma had partial responses to an investigational compound in an early-stage study led by UNC Lineberger's Stergios Moschos, MD.

Stergios Moschos, MD, a UNC Lineberger member, a clinical associate professor of medicine at the University of North Carolina School of Medicine Division of Hematology/Oncology, presented on research efforts to find new melanoma treatments and advances.

At the 10th Annual UNC Conference on Melanoma and Complex Skin Cancers: A Multidisciplinary Perspective, experts in melanoma treatment presented advances in treating the disease on Thursday. The conference, held at the William and Ida Friday Center for Continuing Education, drew dermatologists, surgeons, medical oncologists and other health care providers to hear presentations on topics ranging from immunotherapy drugs and targeted treatments for metastatic disease, radiation strategies, and chemotherapy to prevent skin cancer.

Frances Collichio, MD, is a researcher with the UNC Lineberger Comprehensive Cancer Center and a clinical professor in the UNC School of Medicine Division of Hematology/Oncology.

UNC Lineberger member Frances Collichio, MD, was an investigator for a clinical trial for a treatment that uses a modified virus against melanoma. The treatment meant remission for Willis Davis, who had been diagnosed with stage IIIc melanoma in 2009.

UNC Lineberger researchers significantly contributed to a better understanding of the genetic alterations found in cutaneous melanoma as part of a multi-institution, international effort of The Cancer Genome Atlas (TCGA). Researchers collected samples from 331 patients and used several molecular methodologies to complete the study, the largest of its kind to-date for cutaneous melanoma. The findings were published in the journal Cell.

A new treatment for melanoma could be on the horizon, thanks to a finding by a UNC Lineberger Comprehensive Cancer Center-led team. In the study, which was published online today in the journal Clinical Cancer Research, the authors report that they found high levels of an enzyme in melanoma samples that they believe is a potential drug target.

A UNC Lineberger-led study found that people with higher-risk melanoma containing either BRAF or NRAS gene mutations had lower survival rates.

David W. Ollila, MD, and Nancy E. Thomas MD, PhD

The ninth annual UNC Multidisciplinary Melanoma Conference brought more than 120 health care professionals from across the state on Thursday, February 12 to learn about the detection and treatment of melanoma.

This is an intensity-colored image of blood flow in a PECAM1-positive tumor.

The research, led by Andrew C. Dudley, has implications for developing cancer drugs that target blood vessels that feed tumors.

The $1 million award from the Melanoma Research Alliance and the Saban Family Foundation will support research to improve the treatment of melanoma, the most aggressive type of skin cancer.

Tag: Skin Cancer and Melanoma Clinical Program

Melanoma survivors share stories of recovery amid treatment advances

Phase I clinical trial shows some promise for investigational drug for melanoma

Advances in melanoma treatment focus of UNC conference

Working wonders

UNC Lineberger researchers help map genetic mutations in skin cancer

UNC Lineberger study finds new potential melanoma drug target

Lower survival rates connected with high-risk melanoma with mutations, study finds

UNC’s multidisciplinary melanoma conference draws health professionals from around NC

UNC scientists discover hidden subpopulation of melanoma cells

UNC Lineberger receives jointly awarded $1 million research grant to investigate novel target in melanoma